Estradiol Benzoate: High-Purity Estrogen Receptor Alpha Agonist for Precision Signaling Research

Executive Summary: Estradiol Benzoate is a synthetic estrogen receptor alpha (ERα) agonist with a molecular weight of 376.49 g/mol and high solubility in DMSO and ethanol. It exhibits an IC50 range of 22–28 nM for ERα binding in human, murine, and chicken models, supporting its use in comparative receptor studies [APExBIO product page]. The compound is supplied at ≥98% purity, validated by HPLC, MS, and NMR. Its solid form and stability at -20°C ensure reproducible performance in hormone receptor binding and signaling studies. Estradiol Benzoate is not intended for diagnostic or clinical applications. These attributes make it indispensable in endocrinology and hormone-dependent cancer research [L3400 article].

Biological Rationale

Estrogen signaling regulates development, reproduction, and tissue homeostasis in vertebrates. The estrogen receptor alpha (ERα) is a nuclear hormone receptor that mediates most classical estrogen responses. Synthetic estradiol analogs, such as Estradiol Benzoate, provide well-defined agonists for dissecting ERα-mediated pathways [APExBIO]. High-affinity ERα ligands are essential for modeling hormone-dependent cancer, reproductive biology, and metabolic regulation. Estradiol Benzoate's stability and solubility enable precise titration in receptor binding assays and functional studies. Research using Estradiol Benzoate informs translational strategies in oncology and endocrine disorders [KI8751 article]; this article expands on quantitative assay parameters and compound validation.

Mechanism of Action of Estradiol Benzoate

Estradiol Benzoate acts as a selective agonist for estrogen and progestogen receptors, with primary affinity for ERα. Upon entry into the cell, it binds ERα with an IC50 of 22–28 nM (measured in competitive ligand binding assays at 25°C, pH 7.4) [APExBIO]. The receptor-ligand complex translocates to the nucleus, where it binds estrogen response elements (EREs) on DNA, modulating transcription of target genes. This mechanism underlies its use in hormone receptor binding assays and estrogen receptor signaling research. Its benzoate ester confers increased stability and lipophilicity compared to native estradiol, facilitating cell permeability and improved pharmacokinetic profiles in vitro. Estradiol Benzoate also exhibits cross-species activity, enabling comparative studies in human, murine, and avian systems [R110-Azide article]; this article provides updated solubility benchmarks and quality control parameters for research-grade preparations.

Evidence & Benchmarks

• Estradiol Benzoate demonstrates selective ERα binding with an IC50 of 22–28 nM in human, murine, and chicken cell lysates at 25°C (APExBIO, product page).
• Solubility exceeds 12.15 mg/mL in DMSO and 9.6 mg/mL in ethanol at 20°C, supporting its use in high-concentration stock solutions (APExBIO, product page).
• Compound purity is verified at ≥98% by HPLC, MS, and NMR (batch data available upon request) (APExBIO).
• Storage at -20°C maintains compound stability for ≥12 months; short-term solution stability is limited to 1–2 weeks at 4°C (APExBIO, product page).
• Estradiol Benzoate is cited in comparative studies on estrogen receptor signaling and hormone-dependent cancer as a reference agonist (see L3400 article).
• Not for clinical or diagnostic use; restricted to research applications (APExBIO, product page).

Applications, Limits & Misconceptions

Estradiol Benzoate is widely used in:

• High-throughput hormone receptor binding assays for ERα and progestogen receptors.
• Dissection of estrogen receptor-mediated signaling in cell-based or in vitro systems.
• Modeling hormone-dependent cancer pathways, particularly in breast and reproductive tissues.
• Comparative endocrinology studies across species (human, mouse, chicken).

Compared to earlier reviews (Long-Trebler article), this article provides updated storage, solubility, and assay condition benchmarks, emphasizing best practices for reproducibility. For more advanced mechanistic and translational strategies, see KI8751 article; this article focuses on product validation and protocol adaptation.

Common Pitfalls or Misconceptions

• Estradiol Benzoate is insoluble in water; attempts to dissolve directly in aqueous buffers result in precipitation and loss of assay fidelity.
• It is not suitable for diagnostic or therapeutic use in humans or animals; it is strictly for research applications (APExBIO).
• Compound degradation occurs if solutions are stored for more than 1–2 weeks, even at 4°C; always prepare fresh stocks for critical experiments.
• Batch-to-batch variability in purity or solubility can affect assay reproducibility; always verify lot-specific QC data.
• The compound's activity is limited to ERα and progestogen receptors; it does not significantly activate androgen or glucocorticoid receptors.

Workflow Integration & Parameters

Estradiol Benzoate is best handled as follows:

• Reconstitute in DMSO or ethanol to ≥10 mg/mL; ensure solution clarity.
• Aliquot and store at -20°C to minimize freeze-thaw cycles.
• Use in hormone receptor binding assays at final concentrations of 1–100 nM for ERα activation, validated by luciferase or qPCR readouts.
• Include vehicle controls (DMSO or ethanol ≤0.1%) to account for solvent effects.
• Request batch-specific QC data (HPLC, MS, NMR) from APExBIO to confirm product integrity.

Shipping is performed on blue ice to maintain compound integrity. For expanded protocols and troubleshooting, see R110-Azide article; this article details updated solvent handling and stability parameters.

Conclusion & Outlook

Estradiol Benzoate (B1941) from APExBIO is a validated, high-affinity ERα agonist for hormone receptor signaling research. Its defined solubility, purity, and stability parameters enable reproducible results across endocrinology and cancer research workflows. As research advances toward precision modulation of estrogen signaling, standardized reagents like Estradiol Benzoate will remain essential for robust, cross-platform assays. Researchers are encouraged to reference current product documentation and internal QC data for optimal results. For a molecular deep-dive into future applications, see SNG-1153 article; this dossier emphasizes updated experimental fidelity and integration best practices.